Cited by 161Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms

Oligodendroglial TNFR2 mediates membrane TNF-dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination

Open access
Madsen, Pernille M., Motti, Dario, Karmally, Shaffiat, Szymkowski, David E., Lambertsen, Kate Lykke, Bethea, John R., Brambilla, Roberta·2016·The Journal of Neuroscience

Abstract

Tumor necrosis factor (TNF) is associated with the pathophysiology of various neurological disorders, including multiple sclerosis. It exists as a transmembrane form tmTNF, signaling via TNF receptor 2 (TNFR2) and TNFR1, and a soluble form, solTNF, signaling via TNFR1. Multiple sclerosis is associated with the detrimental effects of solTNF acting through TNFR1, while tmTNF promotes repair and remyelination. Here we demonstrate that oligodendroglial TNFR2 is a key mediator of tmTNF-dependent protection in experimental autoimmune encephalomyelitis (EAE). CNP-cre:TNFR2 fl/fl mice with TNFR2 ablation in oligodendrocytes show exacerbation of the disease with increased axon and myelin pathology, reduced remyelination, and increased loss of oligodendrocyte precursor cells and mature oligodendrocytes. The clinical course of EAE is not improved by the solTNF inhibitor XPro1595 in CNP-cre:TNFR2 fl/fl mice, indicating that for tmTNF to promote recovery TNFR2 in oligodendrocytes is required. We show that TNFR2 drives differentiation of oligodendrocyte precursor cells, but not proliferation or survival. TNFR2 ablation leads to dysregulated expression of microRNAs, among which are regulators of oligodendrocyte differentiation and inflammation, including miR-7a. Our data provide the first direct in vivo evidence that TNFR2 in oligodendrocytes is important for oligodendrocyte differentiation, thereby sustaining tmTNF-dependent repair in neuroimmune disease. Our studies identify TNFR2 in the CNS as a molecular target for the development of remyelinating agents, addressing the most pressing need in multiple sclerosis therapy nowadays. SIGNIFICANCE STATEMENT Our study, using novel TNF receptor 2 (TNFR2) conditional KO mice with selective TNFR2 ablation in oligodendrocytes, provides the first direct evidence that TNFR2 is an important signal for oligodendrocyte differentiation. Following activation by transmembrane TNF, TNFR2 initiates pathways that drive oligodendrocytes into a reparative mode contributing to remyelination following disease. This identifies TNFR2 as a new molecular target for the development of therapeutic agents in multiple sclerosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.0211-16.2016

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The differentiation of local oligodendrocyte progenitor cells into actively myelinating oligodendrocytes is stimulated by innate immune cells.

    “Recent data have indicated that the differentiation of local oligodendrocyte progenitor cells into actively myelinating oligodendrocytes is stimulated by innate immune cells.64-67”

    From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [65]

    The Discussion reports that TNFR2 activation in oligodendrocyte progenitor cells promotes their differentiation and sustains remyelination; the Results section also finds impaired differentiation when TNFR2 is absent. However, the cited passages do not establish that innate immune cells provide the stimulus, and the paper’s purified progenitor-cell cultures contained no microglia. Page numbers were not available in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • TNFα activity is elevated in MS lesions, and blockade of soluble TNF improves outcomes in EAE.

    “TNFα activity is elevated in MS lesions, and blockade of soluble TNF improves outcomes in EAE, supporting a potentially detrimental role of excessive TNF signaling during inflammatory demyelination52.”
  • Excessive TNF signaling during inflammatory demyelination is potentially detrimental.

    “TNFα activity is elevated in MS lesions, and blockade of soluble TNF improves outcomes in EAE, supporting a potentially detrimental role of excessive TNF signaling during inflammatory demyelination52.”
  • The Cnp Cre driver line recombines floxed genes to virtually 100% in oligodendrocytes and up to 60% of OPCs.

    “that recombines floxed genes to virtually 100% in oligodendrocytes and up to 60% of OPCs (Madsen et al., 2016;Saab et al., 2016;Vajda et al., 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L (1998) Oligodendrocyte apoptosis and primary demyelina- tion induced by local TNF/p55TNF receptor signaling in the central ner- vous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 153:801-813. CrossRef Medline · DOI
  2. Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL, Kollias G (2006) Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur J Immunol 36:2768 -2780. CrossRef Medline · DOI
  3. Baba Y, Aihara Y, Watanabe S (2015) MicroRNA-7a regulates Muller glia differentiation by attenuating Notch3 expression. Exp Eye Res 138: 59 -65. CrossRef Medline · DOI
  4. Baker D, Butler D, Scallon BJ, O'Neill JK, Turk JL, Feldmann M (1994) Control of established experimental allergic encephalomyelitis by inhibi- tion of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol 24:2040 -2048. CrossRef Medline · DOI
  5. Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, Bethea JR (2011) Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and pro- motes axon preservation and remyelination. Brain 134:2736 -2754. CrossRef Medline · DOI
  6. Brambilla R, Morton PD, Ashbaugh JJ, Karmally S, Lambertsen KL, Bethea JR (2014) Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia 62: 452-467. CrossRef Medline · DOI
  7. Chen Y, Du J, Zhang Z, Liu T, Shi Y, Ge X, Li YC (2014) MicroRNA-346 mediates tumor necrosis factor alpha-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis 20:1910 -1918. CrossRef Medline · DOI
  8. Dal Canto RA, Shaw MK, Nolan GP, Steinman L, Fathman CG (1999) Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates ex- perimental autoimmune encephalomyelitis. Clin Immunol 90:10 -14. CrossRef Medline · DOI
  9. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z, Pei G (2009) MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10:1252-1259. CrossRef Medline · DOI · Paper page
  10. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA (2010) Dicer1 and miR-219 Are re- quired for normal oligodendrocyte differentiation and myelination. Neu- ron 65:597-611. CrossRef Medline · DOI · Paper page
  11. Fischer R, Wajant H, Kontermann R, Pfizenmaier K, Maier O (2014) Astrocyte-specific activation of TNFR2 promotes oligodendrocyte matu- ration by secretion of leukemia inhibitory factor. Glia 62:272-283. CrossRef Medline · DOI
  12. Grell M, Douni E, Wajant H, Lo ¨hden M, Clauss M, Maxeiner B, Georgopou- los S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802. CrossRef Medline · DOI
  13. Hagemeyer N, Goebbels S, Papiol S, Ka ¨stner A, Hofer S, Begemann M, Gerwig UC, Boretius S, Wieser GL, Ronnenberg A, Gurvich A, Heckers SH, Frahm J, Nave KA, Ehrenreich H (2012) A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med 4:528 -539. CrossRef Medline · DOI
  14. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495:384 -388. CrossRef Medline · DOI · Paper page
  15. He X, Yu Y, Awatramani R, Lu QR (2012) Unwrapping myelination by microRNAs. Neuroscientist 18:45-55. CrossRef Medline · DOI
  16. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612. CrossRef Medline · DOI
  17. Holtmann MH, Neurath MF (2004) Differential TNF-signaling in chronic inflammatory disorders. Curr Mol Med 4:439 -444. CrossRef Medline · DOI
  18. Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M (2014) miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Gene 544:128 -133. CrossRef Medline · DOI
  19. Ingwersen J, Menge T, Wingerath B, Kaya D, Graf J, Prozorovski T, Keller A, Backes C, Beier M, Scheffler M, Dehmel T, Kieseier BC, Hartung HP, Ku ¨ry P, Aktas O (2015) Natalizumab restores aberrant miRNA expres- sion profile in multiple sclerosis and reveals a critical role for miR-20b. Ann Clin Transl Neurol 2:43-55. CrossRef Medline · DOI
  20. Juryn ´czyk M, Selmaj K (2010) Notch: a new player in MS mechanisms. J Neuroimmunol 218:3-11. CrossRef Medline · DOI
  21. Ko ¨rner H, Riminton DS, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD (1997) Critical points of tumor necrosis factor action in central ner- vous system autoimmune inflammation defined by gene targeting. J Exp Med 186:1585-1590. CrossRef Medline · DOI
  22. Kremer D, Ku ¨ry P, Dutta R (2015) Promoting remyelination in multiple sclerosis: current drugs and future prospects. Mult Scler 21:541-549. CrossRef Medline · DOI
  23. Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/ cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53. CrossRef Medline · DOI
  24. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Blueth- mann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29:1319 -1330. CrossRef Medline · DOI
  25. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366 -374. CrossRef Medline · DOI · Paper page
  26. Lenercept Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53:457-465. CrossRef Medline · DOI
  27. Liu C, Tang J (2014) Expression levels of tumor necrosis factor-alpha and the corresponding receptors are correlated with trauma severity. Oncol Lett 8:2747-2751. CrossRef Medline · DOI
  28. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78 -83. CrossRef Medline · DOI
  29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. CrossRef Medline · DOI · Paper page
  30. Madsen PM, Clausen BH, Degn M, Thyssen S, Kristensen LK, Svensson M, Ditzel N, Finsen B, Deierborg T, Brambilla R, Lambertsen KL (2015) Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia. J Cereb Blood Flow Metab. Advance online publication. Retrieved 2 April 2016. doi:10.1177/0271678X15610339. CrossRef Medline · DOI
  31. Maier O, Fischer R, Agresti C, Pfizenmaier K (2013) TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress. Biochem Bio- phys Res Commun 440:336 -341. CrossRef Medline · DOI
  32. Maimone D, Gregory S, Arnason BG, Reder AT (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32:67-74. CrossRef Medline · DOI
  33. McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: im- plications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45. CrossRef Medline · DOI
  34. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Spele- man F, Vandesompele J (2009) A novel and universal method for mi- croRNA RT-qPCR data normalization. Genome Biol 10:R64. CrossRef Medline · DOI · Paper page
  35. Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, Klein RS (2012) Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta Neuropathol 124:847-860. CrossRef Medline · DOI · Paper page
  36. Probert L (2015) TNF and its receptors in the CNS: the essential, the desir- able and the deleterious effects. Neuroscience 302:2-22. CrossRef Medline · DOI
  37. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A 92:11294 -11298. CrossRef Medline · DOI
  38. Pusic AD, Kraig RP (2015) Phasic treatment with interferon gamma stimu- lates release of exosomes that protect against spreading depression. J In- terferon Cytokine Res 35:795-807. CrossRef Medline · DOI
  39. Rangachari M, Kuchroo VK (2013) Using EAE to better understand princi- ples of immune function and autoimmune pathology. J Autoimmun 45: 31-39. CrossRef Medline · DOI
  40. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyeli- tis. J Exp Med 172:1193-1200. CrossRef Medline · DOI
  41. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991) Identification of lym- photoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949 -954. CrossRef Medline · DOI
  42. Sharief MK, Hentges R (1991) Association between tumor necrosis factor- alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325:467-472. CrossRef Medline · DOI
  43. Sua ´rez Y, Wang C, Manes TD, Pober JS (2010) Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercel- lular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 184:21-25. CrossRef Medline · DOI
  44. Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD (2000) Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell Immunol 205:24 -33. CrossRef Medline · DOI
  45. Veroni C, Gabriele L, Canini I, Castiello L, Coccia E, Remoli ME, Columba- Cabezas S, Arico `E, Aloisi F, Agresti C (2010) Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Mol Cell Neurosci 45:234 -244. CrossRef Medline · DOI
  46. Vielhauer V, Stavrakis G, Mayadas TN (2005) Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomer- ulonephritis. J Clin Invest 115:1199 -1209. CrossRef Medline · DOI
  47. Wieser GL, Gerwig UC, Adamcio B, Barrette B, Nave KA, Ehrenreich H, Goebbels S (2013) Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury. Glia 61:869 -880. CrossRef Medline · DOI
  48. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, Hoang T, Xu X, Mi QS, Xin M, Wang F, Appel B, Lu QR (2010) MicroRNA-mediated control of oligo- dendrocyte differentiation. Neuron 65:612-626. CrossRef Medline · DOI · Paper page
  49. Zhao X, Wu J, Zheng M, Gao F, Ju G (2012) Specification and maintenance of oligodendrocyte precursor cells from neural progenitor cells: involve- ment of microRNA-7a. Mol Biol Cell 23:2867-2878. CrossRef Medline · DOI

Cited by

Sorted by citations

Authors
Madsen, P. M., Motti, D., Karmally, S., Szymkowski, D. E., Lambertsen, K. L., Bethea, J. R., & Brambilla, R.
Affiliations
  • University of Miami (US)
  • Nationwide Children's Hospital (US)
  • Xencor (United States) (US)
  • University of Southern Denmark (DK)
  • Drexel University (US)
Venue
The Journal of Neuroscience
Published
2016-05-04
Volume
36
Issue
18
Pages
5128-5143
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2325615207
Cited by
161
References
3
Citations by year
2026: 15 · 2025: 12 · 2024: 17 · 2023: 23 · 2022: 14 · 2021: 17 · 2020: 17 · 2019: 20 · 2018: 11 · 2017: 10 · 2016: 4
FWCI
13.63
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, other-oa)
Funders
  • Scleroseforeningen
  • National Institute of Neurological Disorders and Stroke (R21NS084303, R01NS051709)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
TNF receptor 2, transmembrane TNF, oligodendrocyte differentiation, remyelination, experimental autoimmune encephalomyelitis, multiple sclerosis, oligodendrocyte precursor cells, microRNA, XPro1595, TNF receptor 1, neuroinflammation, conditional knockout
MeSH terms
Animals, Axons, Behavior, Animal, Cell Differentiation, Cell Survival, Encephalomyelitis, Autoimmune, Experimental, Female, Gene Expression Regulation, Male, Myelin Sheath, Nerve Regeneration, Neuroglia, Tumor Necrosis Factor-alpha, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type II, Mice, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review